Article
Combinatorial drug design targeting multiple cancer signaling networks controlled by mitochondrial Hsp90.
The Journal of clinical investigation - 1 Mar 2009
Kang Byoung Heon, Plescia Janet, Song Ho Young, Meli Massimiliano, Colombo Giorgio, Beebe Kristin, Scroggins Bradley, Neckers Len, Altieri Dario C
Abstract excerpt
Although therapeutically targeting a single signaling pathway that drives tumor development and/or progression has been effective for a number of cancers, in many cases this approach has not been successful. Targeting networks of signaling pathways, instead of isolated pathways, may overcome this problem, which is probably due to the extreme heterogeneity of human tumors. However, the possibility that such...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
